1. Assessment of the effect of IL-4 on IgE antibody high-affinity (FceRI) and low-affinity (FceRII) receptor mRNA expression on primary human aortic endothelial cells. Issue 1 (July 2015) Authors: Gorzelak-Pabis, P.; Wojdan, K.; Luczak, E.; Antosik, K.; Borowiec, M.; Chalubinski, M.; Broncel, M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of lipid-lowering therapy in patients with definite diagnosis of heterozygous familial hypercholesterolemia in Lodz. (August 2022) Authors: Gorzelak-Pabiś, P.; Pawlos, A.; Staciwa, Z.; Krulikowska, A.; Broncel, M. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HIV patients in the glaring light of the new ESC dyslipidaemias 2019 guidelines. Unattainable goals or a therapeutic nihilism?. (December 2020) Authors: Sanetra, A.; Wlazłowska, E.; Jabłonowska, E.; Broncel, M.; Gorzelak-Pabis, P. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Protective effect of atorvastatin, rosuvastatin and ezetimibe on the integrity and inflammatory properties in a model of vascular endothelial damage with oxidized cholesterol. (December 2020) Authors: Niedzielski, M.; Gorzelak-Pabiś, P.; Broncel, M.; Woźniak, E. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SGLT2 inhibitors may reverse the damaging effect of oxidized cholesterol on the integrity of HUVECs and alleviate associated inflammatory response. (August 2022) Authors: Pawlos, A.; Broncel, M.; Woźniak, E.; Gorzelak-Pabiś, P. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Statin use and sleep disturbance – Own experience. (August 2018) Authors: Trambowicz, K.; Gorzelak-Pabis, P.; Durma, A.; Pypec, A.; Lis, E.; Rozmarynowska, I.; Jurzak, N.; Ignaczak, M.; Broncel, M. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Statins And Sleep – Clinical Effects. (August 2019) Authors: Trambowicz, K.; Gorzelak-Pabiś, P.; Broncel, M. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The effect of high-fat diet on the barrier functions and inflammatory status of human vascular endothelial cells. (September 2016) Authors: Gorzelak-Pabis, P.; Luczak, E.; Wojdan, K.; Broncel, M.; Chalubinski, M. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The prevalence of familiar hypercholesterolemia in patients of Lodz hospital and their treatment analysis. (August 2018) Authors: Gorzelak-pabis, P.; Pawlik, A.; Kovtsun, J.; Sanz Rekalde, L.; Broncel, M. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The protective effect of dabigatran and rivaroxaban on DNA oxidative changes in a model of vascular endothelial damage with oxidized cholesterol. (December 2020) Authors: Woźniak, E.; Broncel, M.; Bukowska, B.; Gorzelak-Pabiś, P. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗